Showing 1 - 8 results of 8 for search 'T.B. Malankhanova', query time: 0.03s Refine Results
  1. 1
    Huntington’s disease modeling on HEK293 cell line

    Huntington’s disease modeling on HEK293 cell line by D. V. Sharipova, T. B. Malankhanova, A. A. Malakhova

    Published 2017-12-01
    Get full text
    Article
  2. 2
    The Cutting Edge of Disease Modeling: Synergy of Induced Pluripotent Stem Cell Technology and Genetically Encoded Biosensors

    The Cutting Edge of Disease Modeling: Synergy of Induced Pluripotent Stem Cell Technology and Genetically Encoded Biosensors by Kamila R. Valetdinova, Tuyana B. Malankhanova, Suren M. Zakian, Sergey P. Medvedev

    Published 2021-08-01
    Get full text
    Article
  3. 3
    Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells.

    Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells. by Ksenia N Morozova, Lyubov A Suldina, Tuyana B Malankhanova, Elena V Grigor'eva, Suren M Zakian, Elena Kiseleva, Anastasia A Malakhova

    Published 2018-01-01
    Get full text
    Article
  4. 4
    Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease

    Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease by A.A. Malakhova, E.V. Grigor'eva, T.B. Malankhanova, S.V. Pavlova, K.R. Valetdinova, N.Yu. Abramycheva, A.S. Vetchinova, S.N. Illarioshkin, S.M. Zakian

    Published 2020-04-01
    Get full text
    Article
  5. 5
    Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease

    Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease by E.V. Grigor'eva, T.B. Malankhanova, A. Surumbayeva, J.M. Minina, V.V. Morozov, N. Yu Abramycheva, S.N. Illarioshkin, A.A. Malakhova, S.M. Zakian

    Published 2019-01-01
    Get full text
    Article
  6. 6
    Generation of induced pluripotent stem cell line, ICGi033-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease

    Generation of induced pluripotent stem cell line, ICGi033-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease by Elena V. Grigor'eva, Anastasia A. Malakhova, Diana A. Sorogina, Sofia V. Pavlova, Tuyana B. Malankhanova, Natalia Yu. Abramycheva, Sergey A. Klyushnikov, Sergey N. Illarioshkin, Suren M. Zakian

    Published 2022-08-01
    Get full text
    Article
  7. 7
    Generation of two iPSC lines (ICGi008-A and ICGi008-B) from skin fibroblasts of a patient with early-onset Alzheimer's disease caused by London familial APP mutation (V717I)

    Generation of two iPSC lines (ICGi008-A and ICGi008-B) from skin fibroblasts of a patient with early-onset Alzheimer's disease caused by London familial APP mutation (V717I) by E.V. Grigor'eva, T.B. Malankhanova, E.I. Ustyantseva, J.M. Minina, O.E. Redina, V.V. Morozov, A.I. Shevela, S.M. Zakian, S.P. Medvedev

    Published 2019-04-01
    Get full text
    Article
  8. 8
    Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S <i>GBA</i> Variant Carriers with and without Parkinson’s Disease

    Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S <i>GBA</i> Variant Carriers with and without Parkinson’s Disease by Elena V. Grigor’eva, Alena E. Kopytova, Elena S. Yarkova, Sophia V. Pavlova, Diana A. Sorogina, Anastasia A. Malakhova, Tuyana B. Malankhanova, Galina V. Baydakova, Ekaterina Y. Zakharova, Sergey P. Medvedev, Sofia N. Pchelina, Suren M. Zakian

    Published 2023-02-01
    Get full text
    Article

Search Tools: